- Home
- RLAY vs TMP Comparison
RLAY vs TMP Comparison
Compare RLAY & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- TMP
- Stock Information
- Founded
- RLAY 2015
- TMP 1836
- Country
- RLAY United States
- TMP United States
- Employees
- RLAY N/A
- TMP N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- TMP Major Banks
- Sector
- RLAY Health Care
- TMP Finance
- Exchange
- RLAY Nasdaq
- TMP Nasdaq
- Market Cap
- RLAY 576.1M
- TMP 878.2M
- IPO Year
- RLAY 2020
- TMP N/A
- Fundamental
- Price
- RLAY $3.52
- TMP $64.98
- Analyst Decision
- RLAY Strong Buy
- TMP Buy
- Analyst Count
- RLAY 11
- TMP 2
- Target Price
- RLAY $18.40
- TMP $69.00
- AVG Volume (30 Days)
- RLAY 1.5M
- TMP 54.8K
- Earning Date
- RLAY 08-05-2025
- TMP 07-25-2025
- Dividend Yield
- RLAY N/A
- TMP 3.71%
- EPS Growth
- RLAY N/A
- TMP 980.13
- EPS
- RLAY N/A
- TMP 5.16
- Revenue
- RLAY $7,679,000.00
- TMP $297,067,000.00
- Revenue This Year
- RLAY $17.59
- TMP $13.79
- Revenue Next Year
- RLAY N/A
- TMP $6.90
- P/E Ratio
- RLAY N/A
- TMP $12.95
- Revenue Growth
- RLAY N/A
- TMP 40.19
- 52 Week Low
- RLAY $1.78
- TMP $52.73
- 52 Week High
- RLAY $10.72
- TMP $79.01
- Technical
- Relative Strength Index (RSI)
- RLAY 54.94
- TMP 62.30
- Support Level
- RLAY $3.50
- TMP $65.49
- Resistance Level
- RLAY $3.74
- TMP $66.91
- Average True Range (ATR)
- RLAY 0.18
- TMP 1.43
- MACD
- RLAY -0.00
- TMP 0.25
- Stochastic Oscillator
- RLAY 58.55
- TMP 83.28
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.